Description
The study is open to men & women with triple negative breast cancer that have received chemotherapy prior to surgery, then had surgery to remove the breast cancer, and viable tumor was still seen in the surgery specimen.
Overview
The main purpose of this study is to compare getting more treatment with capecitabine (i.e. one of the usual approaches), to any good and bad effects of getting more treatment with a platinum based chemotherapy (cisplatin or carboplatin), after surgery.
What we're hoping for
We are hoping that a platinum-based chemotherapy after surgery could prevent triple negative breast cancer from returning (metastatic recurrence) for people who have undergone chemotherapy prior to surgery.
Additional Information
ClinicalTrials.gov Identifier: NCT02445391